🔎 Trials Near Me

Hjem › Plateepitelcancer i hode og hals › Louisiana

Kliniske studier for Plateepitelcancer i hode og hals i Louisiana

6 studier for Plateepitelcancer i hode og hals søker deltakere på steder i Louisiana.

Byer i Louisiana

Offisiell studietekst (engelsk)

Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer

  • Ochsner Medical Center Jefferson, New Orleans
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06980038

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  • Tulane Cancer Center, New Orleans
  • Christus Highland/ Boniol, Shreveport
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT05059444

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

  • Louisiana State University Health Science Center, New Orleans
  • University Medical Center New Orleans, New Orleans
  • Touro Infirmary, New Orleans
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT02734537

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

  • Louisiana State University Health Sciences Center, New Orleans
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 7. jul. 2026 · NCT05768139

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

  • Mary Bird Perkins Cancer Center, Baton Rouge
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 9. apr. 2026 · NCT06064877

A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors

  • LSU Health Sciences Center, Shreveport
RekruttererTidlig fase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 11. aug. 2025 · NCT06700070

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.